Skip to content
Pharma Observatory a Scientist.com platform

Condition (MeSH)

Sphincter of Oddi Dysfunction

ClinicalTrials.gov lists 12 trials for Sphincter of Oddi Dysfunction or a narrower condition beneath it.

MeSH D046628 Digestive System Diseases C06
Email me this page as a PDF

Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Phase 3 Phase 3 1 Phase 4 Phase 4 2 Not applicable Not applicable 7 Observational Observational 2 Phase 3 Phase 3 1 Phase 4 Phase 4 2 Not applicable Not applicable 7 Observational Observational 2

Trials per phase

12 of the 12 trials are tagged with Sphincter of Oddi Dysfunction itself; the rest are tagged with a narrower condition beneath it.

Get the Sphincter of Oddi Dysfunction report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

When did Sphincter of Oddi Dysfunction trials start? (11)

Shown in this order: most recent first, 1990 onwards. 2026 is partial: trials registered with a 2026 start date so far, not a full year.

Trials over time, by phase

  • Phase 3
  • Phase 4
  • Not applicable
  • Observational

Top of scale: 2

1997: 1 trials (Not applicable 1) 2005: 1 trials (Observational 1) 2006: 1 trials (Phase 3 1) 2008: 1 trials (Not applicable 1) 2009: 1 trials (Phase 4 1) 2010: 1 trials (Not applicable 1) 2016: 2 trials (Not applicable 1, Phase 4 1) 2017: 1 trials (Not applicable 1) 2019: 1 trials (Not applicable 1) 2022: 1 trials (Not applicable 1) 2024: 1 trials (Observational 1)

Trials registered with a start date in each year, 1990 onward, stacked by phase (complete years only; the current partial year is in the table's notes). The table below lists the same counts, most recent years first.

Trials started per year
Year Trials started
2024 1
2022 1
2019 1
2017 1
2016 2
2010 1
2009 1
2008 1
2006 1
2005 1

No forecast is made for this condition: it averages 0.4 trial starts a year over the five years to September, under the 5 a year the method needs.

Recruitment duration, a model prediction: 1 trial still running at the 2026-10-09 snapshot, fewer than the 5 needed for a median. Source: ClinicalTrials.gov / AACT (CTTI), public domain.

What phase are Sphincter of Oddi Dysfunction trials in? (4)

Shown in this order: phase order.

Show the trials by phase as a table
Trials by phase
Phase Trials
Phase 3 1
Phase 4 2
Not applicable 7
Observational 2

How many Sphincter of Oddi Dysfunction trials are recruiting? (4)

Shown in this order: the order a trial moves through, from not yet recruiting to unknown.

Trials by recruitment status
Status Trials
Recruiting 3
Completed 6
Terminated 2
Unknown status 1

Status as registered on ClinicalTrials.gov. Each trial is counted once.

Which drugs are being tested for Sphincter of Oddi Dysfunction? (3)

Shown in this order: most trials first. One row per drug, matched to a single molecule under all its names, ranked by number of trials.

Drugs tested
Drug Trials
Neostigmine 1
Duloxetine 1
Pinaverium 1

Interventions as named in the registry (3)

Shown in this order: most trials first.

Interventions as named in the registry
Drug Trials
Secretin 1
PO Morphine 1
Danshu Capsules 1

These are the names sponsors entered on ClinicalTrials.gov that we have not matched to a single molecule. Some are drugs under a brand or code name; others are procedures, doses or arm labels.

Which serious adverse events do Sphincter of Oddi Dysfunction trials report? (2)

Shown in this order: most subjects affected first. Subjects affected summed across trials, a cross-trial signal, not a rate.

Serious adverse events in this condition's trials
Adverse event Subjects affected Trials
Pancreatitis 26 1
Perforation 2 1

Which publications cover Sphincter of Oddi Dysfunction? (16)

Shown in this order: major-topic papers first, then newest, then most linked to trials.

Not on this page

Not measured: delivery record.

Checked, with nothing recorded for this condition: lead sponsors, prevalence, rare-disease identity, and sub-conditions in mesh.

Browse all condition evidence pages